Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neonatal alloimmune thrombocytopenia]

H Ohto1

  • 1Blood Transfusion Service, Fukushima Medical College.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 25, 1997
PubMed
Summary

Neonatal alloimmune thrombocytopenia (NAIT) is a condition where maternal antibodies target fetal platelets. Early detection and compatible platelet transfusions are crucial for managing severe NAIT cases and preventing intracranial hemorrhage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between evacuation and becoming overweight after the Great East Japan Earthquake: a 7-year follow-up of the Fukushima Health Management Survey.

Public health·2024
Same author

The KANNO blood group system.

Immunohematology·2023
Same author

Impact of prestorage leucoreduction of autologous whole blood on length of hospital stay with a subgroup analysis in bilateral hip arthroplasty.

Vox sanguinis·2018
Same author

Evacuation is a risk factor for diabetes development among evacuees of the Great East Japan earthquake: A 4-year follow-up of the Fukushima Health Management Survey.

Diabetes & metabolism·2017
Same author

EXTERNAL AND INTERNAL EXPOSURE TO FUKUSHIMA RESIDENTS.

Radiation protection dosimetry·2016
Same author

T-cell-replete haploidentical stem cell transplantation is highly efficacious for relapsed and refractory childhood acute leukaemia.

Transfusion medicine (Oxford, England)·2014

Area of Science:

  • Immunology
  • Hematology
  • Perinatology

Context:

  • Neonatal alloimmune thrombocytopenia (NAIT) is a significant cause of fetal and neonatal morbidity.
  • Maternal antibodies against fetal platelet alloantigens trigger NAIT.
  • Key human platelet antigens (HPAs) involved include HPA-1, -2, -3, -4, and -5.

Purpose:

  • To review the epidemiology, causes, and management of NAIT.
  • To highlight the prevalence of specific HPA incompatibilities in different populations.
  • To discuss therapeutic strategies for affected neonates and fetuses.

Summary:

  • Alloimmunization to platelet antigens affects 0.94% of pregnant Japanese women, with NAIT occurring at an estimated 1:3300 births.
  • HPA-4 incompatibility is the primary cause (80%) of NAIT in this population, followed by HPA-3a (15%).
  • Intracranial hemorrhage can occur unpredictably, even in first pregnancies. Treatment involves compatible, irradiated platelet transfusions and potentially intravenous immunoglobulin.

Impact:

  • Understanding NAIT's genetic and immunologic basis is vital for accurate diagnosis and risk assessment.
  • Effective management strategies, including transfusion protocols, can significantly reduce NAIT-related mortality and morbidity.
  • Further research into intravenous immunoglobulin's role may offer new therapeutic avenues for NAIT.

Related Experiment Videos